Ten new procedure added to private reimbursement schedule in England

28

Feb 2020

The Clinical Coding and Schedule Development (CCSD) group develops and maintains procedural and diagnostics nomenclature for private payers in England. New procedure codes concern repair of femoral hernia requiring removal of previously inserted mesh, transurethral non-ablative radiofrequency of bladder, minimally invasive mitral valve repair, two-stage revision of total hip replacement for infection and others. The codes are introduced with a recommended adoption date being the 1st of May 2020. The document also contains a list of textual changes in codes, unacceptable combinations, and inactivated codes. There were no changes to the CCSD Schedule of Diagnostic Tests.

The CCSD Group approved the following procedure codes for publication to the CCSD Schedule in January 2020 with a recommended adoption date being the 1st of May 2020:

  • 2 stage revision of total hip replacement for infection - first stage (W3742)
  • 2 stage revision of total hip replacement for infection - second stage (W3743)
  • Midcarpal hemiarthroplasty for wrist arthritis (W5320)
  • Transurethral non-ablative radiofrequency of bladder (M4940)
  • Repair of femoral hernia requiring removal of previously inserted mesh (T2203)
  • Repair of inguinal hernia requiring removal of previously inserted mesh (T2003)
  • Repair of umbilical hernia requiring removal of previously inserted mesh (T2403)
  • Minimally invasive mitral valve repair (K2581)
  • Arthroscopic superior capsule reconstruction for irreparable rotator cuff tears +/ -decompression (including graft) (W7716)
  • Surgical aortic root repair using Personalised External Aortic Root Support (PEARS) (K3300)

See the full details here.

There were no changes to the CCSD Schedule of Diagnostic Tests. Link

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more